Cargando…
A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION
NOT PUBLISHED AT AUTHOR’S REQUEST Funding Agencies: None
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859363/ http://dx.doi.org/10.1093/jcag/gwab049.041 |
| _version_ | 1784654442364141568 |
|---|---|
| author | Crowley, E Turner, D Ma, C Nguyen, T McKay, H Schneider, R Silverberg, A Muise, A Feagan, B Griffiths, A Jairath, V |
| author_facet | Crowley, E Turner, D Ma, C Nguyen, T McKay, H Schneider, R Silverberg, A Muise, A Feagan, B Griffiths, A Jairath, V |
| author_sort | Crowley, E |
| collection | PubMed |
| description | NOT PUBLISHED AT AUTHOR’S REQUEST Funding Agencies: None |
| format | Online Article Text |
| id | pubmed-8859363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88593632022-02-22 A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION Crowley, E Turner, D Ma, C Nguyen, T McKay, H Schneider, R Silverberg, A Muise, A Feagan, B Griffiths, A Jairath, V J Can Assoc Gastroenterol Poster of Distinction NOT PUBLISHED AT AUTHOR’S REQUEST Funding Agencies: None Oxford University Press 2022-02-21 /pmc/articles/PMC8859363/ http://dx.doi.org/10.1093/jcag/gwab049.041 Text en ڣ The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster of Distinction Crowley, E Turner, D Ma, C Nguyen, T McKay, H Schneider, R Silverberg, A Muise, A Feagan, B Griffiths, A Jairath, V A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION |
| title | A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION |
| title_full | A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION |
| title_fullStr | A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION |
| title_full_unstemmed | A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION |
| title_short | A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION |
| title_sort | a42 heterogeneity in efficacy and safety endpoints for pediatric clinical trials in inflammatory bowel disease: a need for harmonization |
| topic | Poster of Distinction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859363/ http://dx.doi.org/10.1093/jcag/gwab049.041 |
| work_keys_str_mv | AT crowleye a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT turnerd a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT mac a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT nguyent a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT mckayh a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT schneiderr a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT silverberga a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT muisea a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT feaganb a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT griffithsa a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization AT jairathv a42heterogeneityinefficacyandsafetyendpointsforpediatricclinicaltrialsininflammatoryboweldiseaseaneedforharmonization |